Drug Shortage Report for TEVA-ARIPIPRAZOLE
| Report ID | 86957 |
| Drug Identification Number | 02464187 |
| Brand name | TEVA-ARIPIPRAZOLE |
| Common or Proper name | ARIPIPRAZOLE |
| Company Name | TEVA CANADA LIMITED |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | ARIPIPRAZOLE |
| Strength(s) | 20MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 30 |
| ATC code | N05AX |
| ATC description | ANTIPSYCHOTICS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2019-06-18 |
| Estimated end date | 2019-07-30 |
| Actual end date | 2019-07-30 |
| Shortage status | Resolved |
| Updated date | 2019-08-06 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2019-08-06 | French | Compare |
| v6 | 2019-08-06 | English | Compare |
| v5 | 2019-06-27 | French | Compare |
| v4 | 2019-06-27 | English | Compare |
| v3 | 2019-06-19 | English | Compare |
| v2 | 2019-06-18 | French | Compare |
| v1 | 2019-06-18 | English | Compare |
Showing 1 to 7 of 7